Indian regulator upbeat on trials situation but damage done says industry
This article was originally published in Scrip
Executive Summary
Things are not as gloomy as they are being made out to be in the clinical trials segment in India and industry should work towards "instilling confidence" in the public at large, according to the country's Joint Drugs Controller, Dr V G Somani.